-
Mashup Score: 0RECOVER: Researching COVID to Enhance Recovery - 1 year(s) ago
The long-term effects of COVID are real. Join the NIH in the search for answers.
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Events Demonstrate Value of Community-Engaged Research - 1 year(s) ago
During the 2022 American Public Health Association (APHA) annual meeting and expo, the NIH Community Engagement Alliance (CEAL) highlighted lessons learned from the work of CEAL teams across 21 states. In addition, NHLBI hosted a virtual workshop with involvement from NIMHD and NIA, focused on the science of community-engaged health disparities research.
Source: NIH RecordCategories: Hem/Oncs, Latest HeadlinesTweet-
.@NIHrecord: The #Covid19 pandemic demonstrated the importance of conducting community-engaged research to build #trust, combat #misinformation, sustain long-lasting #partnerships. Photo from @NIH-sponsored events #APHA session in #Boston. https://t.co/BUxxoCs58J #NHLBI #NIHCEAL https://t.co/BENxjPAknz
-
-
Mashup Score: 6Effectiveness of the Bivalent mRNA Vaccine in Preventing Severe COVID-19 Outcomes: An Observational Cohort Study - 1 year(s) ago
Background: During Late 2022, the SARS-CoV-2 Omicron BA.5 sublineages accounted for most of the sequenced viral genomes worldwide. Bivalent mRNA vaccines contai
Source: papers.ssrn.comCategories: Hem/Oncs, Latest HeadlinesTweet-
.@TheLancet #PrePrint: Arbel & colleagues report the real-world #effectiveness of bivalent mRNA #vaccine in preventing severe #COVID19 outcomes: 81% ⬇️COVID-19 related #hospitalizations 86% ⬇️COVID-19 death #VaccinesWork #Variants #NIHCEAL #ImpSci @SSRN https://t.co/jcstvcyoUv https://t.co/f17TX5MBUb
-
-
Mashup Score: 0NIH RECOVER - 1 year(s) ago
The National Institutes of Health (NIH) created the RECOVER Initiative to learn about the long-term effects of COVID. Everyone can join the search for answers to Long COVID. Whether or not you have had COVID, you may be able to participate in RECOVER research.
For more information go to https://recovercovid.org/news-events
Source: NIH VideoCastingCategories: Hem/Oncs, Latest HeadlinesTweet-
.#NIHCEAL: There have been successes in #Tribal communities in addressing the #COVID19 pandemic. Please join members of the #RECOVERcovid Initiative, #NIH_CEAL and @NIH THRO for a webinar on highlights of these successes. December 7at 2pm EST. Watch live: https://t.co/P1Cl9Xyung https://t.co/3jlAkGKy2v
-
-
Mashup Score: 0Vital Signs: Influenza Hospitalizations and Vaccination ... - 1 year(s) ago
This report describes an analysis of influenza hospitalization risk and vaccination coverage in the United States by race and ethnicity during the 2009-10 flu season through the 2021-22 flu season.
Categories: Hem/Oncs, Latest HeadlinesTweet-
.#MMWR: These persistent racial and ethnic #disparities in influenza disease severity are preventable. Increasing uptake of #flu #vaccination is one strategy. #AfricanAmerican #AmericanIndian #AlaskNative #Hispanic #Latino https://t.co/03CLovM7sC #NIHCEAL @NIHCEAL @CDCgov @HHSGov https://t.co/u83OuDjC1r
-
-
Mashup Score: 0
This cross-sectional study describes the temporal dynamics of persistent symptoms after SARS-CoV-2 infection and the factors associated with their resolution.
Source: jamanetwork.comCategories: Hem/Oncs, Latest HeadlinesTweet-
.#LongCovid. #JAMA: Persistent symptoms were still present in 10.1% of infected individuals at 1 year after #SARSCoV2 infection. #Cough #Dyspnea #Taste #Smell #NIHCEAL #RECOVER @NIH @NIHCEAL @NIH_NHLBI @NIMHD @CDCgov https://t.co/yX9TcISKgX https://t.co/8ULfYveJul
-
-
Mashup Score: 0Cardiovascular Drug Interactions With Nirmatrelvir/Ritonavir in Patients With COVID-19: JACC Review Topic of the Week - 1 year(s) ago
Abstract Nirmatrelvir-ritonavir (NMVr) is used to treat symptomatic, nonhospitalized patients with coronavirus disease-2019 (COVID-19) who are at high risk of progression to severe disease. Patient…
Categories: Hem/Oncs, Latest HeadlinesTweet-
.#JACC: Abraham & colleagues describe potential drug-drug interactions of #Paxlovid with commonly used #cardiovascular medications along with grade of interactions and #recommendations regarding any medication adjustments needed. #NIHCEAL #Pharma #COVID19 https://t.co/xcFSWfwUqJ https://t.co/an3sDvo0xD
-
-
Mashup Score: 0
Image Network for Community-Engaged Primary Care Research (NCPCR) supports the CEAL mission by leveraging community-engaged research in primary care settings to address health inequities. The trusted voices of health care providers are enabled as they engage patients within their communities. In this role, primary…
Source: Community Engagement AllianceCategories: Hem/Oncs, Latest HeadlinesTweet-
.@NIHCEAL has a new research #network focused on using community-engaged research in #PrimaryCare settings to help meet #community needs: Network for Community-Engaged Primary Care Research (#NCPCR). @NIH_NHLBI @NIH #NIHCEAL https://t.co/arVDk2ry63 https://t.co/qqwtuvQu4D
-
-
Mashup Score: 0
Learn more about the Advancing the Science of Community-Engaged Health Disparities Research virtual workshop on Nov. 14-15, 2022.
Source: NHLBI NIHCategories: Hem/Oncs, Latest HeadlinesTweet-
.@NIH: Join #NHLBI on November 14-15 for a virtual workshop to discuss lessons learned from #CommunityEngagement efforts, new research methods & the value of partnerships. @NIHCEAL #Disparities #communities #SDOH #NIHCEAL #workshop https://t.co/hLrtj7esRM https://t.co/ryNYl8MCgS
-
-
Mashup Score: 7Can financial incentives and other nudges increase COVID-19 vaccinations among the vaccine hesitant? A randomized trial - 2 year(s) ago
Despite rapid initial uptake, COVID-19 vaccinations in the United States stalled within a few months of widespread rollout in 2021. In response, many …
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet-
.@NIH-funded #RCT: Although messages increased vaccination intentions, none of the interventions meaningfully increased #COVID19 #vaccination rates amongst the vaccine hesitant. Need to find what strategies work in which settings. @NIHCEAL https://t.co/8aQKWnqjLA #NIHCEAL https://t.co/OMgGls85Yr
-
.#LongCOVID: @KFF data: Some good news! Among people who have had #COVID19, the percentage who currently have Long COVID is declining. We still have a lot to learn about this condition. Read about @NIH research on Long COVD at @NIHRECOVER #COVID #NIHCEAL https://t.co/l8IkdHFWVb https://t.co/FRM3AgrrJD